Teva Pharmaceutical: Clinical Trials & Research Profile
Biopharma Industry (Tel Aviv, IL / Parsippany, NJ) · Primary Focus: Rare Genetic, Women's Health, and Other
| Clinical Trial Metric | Verified Public Record |
|---|---|
| Organization Type | Consolidated Trial Sponsor |
| Institutional Sector & Location | Biopharma Industry (Tel Aviv, IL / Parsippany, NJ) |
| Primary Therapeutic Area | Rare Genetic, Women's Health, and Other |
| Active Phase II & III Studies | 6 active (1 recruiting now) |
| Total Tracked Studies (2018 to 2026) | 31 (26 with California sites) |
| Completed vs Early-Stopped Studies | 17 completed / 8 stopped (25.8% stop rate) |
| Median Closed Enrollment | 291 participants |
| FDA Drugs@FDA Original Approvals | 85 all-time (12 from 2018 to 2026) |
| Physical Hospital Site Disclosure | 34.5% named hospital slots |
Related Filings Across Meru Platforms
Verified cross-ledger federal filings for Teva Pharmaceuticals across sibling Meru public-data platforms.
Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk